Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers

Clinical trial NCT02637466 · WITHDRAWN

Trial details

NCT number: NCT02637466
Sponsor: University of Miami
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Unipolar Major Depression Stage I, II or III Breast Cancer

Start date: 2016-07-01
Primary completion: 2018-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.